![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » HACKARD & HOLT ANNOUNCES MORE DIET DRUG HEARTACHE FOR WYETH
HACKARD & HOLT ANNOUNCES MORE DIET DRUG HEARTACHE FOR WYETH
July 28, 2006
The latest diet drug trial against Wyeth is set to commence this week in the Philadelphia Court of Common Pleas with Judge Lisa M. Rau presiding. Plaintiff Jodi Wier's lawsuit alleging that the Wyeth-manufactured
diet drug Pondimin (part of the notorious Fen-phen combination) caused her fatal
case of PPH was filed in 2004 by Theodore J. Holt of Gold River, California.
PR Newswire
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct